Nuveen Asset Management, LLC Keros Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 79,485 shares of KROS stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,485

Previous 261,348 69.59%

Holding current value

$1.37 Million

Previous $15.2 Million 91.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.64 - $70.0 $2.84 Million - $12.7 Million	-181,863 Reduced 69.59%	79,485 $1.26 Million
Q3 2024 Nov 14, 2024	BUY	$41.68 - $58.07 $6.4 Million - $8.92 Million	153,568 Added 142.48%	261,348 $15.2 Million
Q2 2024 Aug 09, 2024	BUY	$44.58 - $66.89 $291,597 - $437,527	6,541 Added 6.46%	107,780 $4.93 Million
Q1 2024 May 13, 2024	BUY	$41.26 - $70.48 $1.06 Million - $1.81 Million	25,643 Added 33.92%	101,239 $6.7 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $124,155 - $187,926	4,578 Added 6.45%	75,596 $3.01 Million

Q3 2023 Nov 14, 2023	BUY	$31.57 - $43.02 $611,163 - $832,824	19,359 Added 37.47%	71,018 $2.26 Million
Q2 2023 Aug 14, 2023	SELL	$37.26 - $51.01 $577,902 - $791,165	-15,510 Reduced 23.09%	51,659 $2.08 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $75,835 - $108,555	1,830 Added 2.8%	67,169 $2.87 Million
Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $25,484 - $33,443	646 Added 1.0%	65,339 $3.14 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $48,733 - $70,330	1,753 Added 2.79%	64,693 $2.43 Million
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $63,643 - $163,912	2,445 Added 4.04%	62,940 $1.74 Million
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $125,601 - $177,011	-2,982 Reduced 4.7%	60,495 $3.08 Million
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $170,893 - $290,866	-4,625 Reduced 6.79%	63,477 $2.97 Million
Q3 2021 Nov 12, 2021	SELL	$29.27 - $43.71 $1.39 Million - $2.07 Million	-47,363 Reduced 41.02%	68,102 $2.09 Million
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $374,052 - $618,510	-8,822 Reduced 7.1%	115,465 $4.9 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $1.58 Million - $2.2 Million	29,275 Added 30.81%	124,287 $7.65 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $2.45 Million - $5.62 Million	67,928 Added 250.8%	95,012 $6.7 Million
Q3 2020 Nov 16, 2020	BUY	$27.04 - $62.21 $3,082 - $7,091	114 Added 0.42%	27,084 $1.05 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $541,557 - $1.09 Million	26,970 New	26,970 $1.01 Million

Others Institutions Holding KROS

# of Institutions

169

Shares Held

35.4M

Call Options Held

574K

Put Options Held

325K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Keros Therapeutics, Inc. Transaction History